Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy. Teijeira A, Garasa S, Luri-Rey C, de Andrea C, et al. Cancer Res 2022;82:4373-4385.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Teijeira A, Garasa S, Luri-Rey C, de Andrea C, et al. Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy. Cancer Res 2022;82:4373-4385.
PMID: 36130020